Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensiti...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47361ecca973405cbbf1642486398298 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:47361ecca973405cbbf1642486398298 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:47361ecca973405cbbf16424863982982021-12-02T15:33:45ZTargeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer10.1038/s41467-018-07258-y2041-1723https://doaj.org/article/47361ecca973405cbbf16424863982982018-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-07258-yhttps://doaj.org/toc/2041-1723The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensitizes resistant cancer cells to growth inhibition.Jingyi LiuZhibing DuanWeijie GuoLei ZengYadi WuYule ChenFang TaiYifan WangYiwei LinQiang ZhangYanling HeJiong DengRachel L. StewartChi WangPengnian Charles LinSaghi GhaffariB. Mark EversSuling LiuMing-Ming ZhouBinhua P. ZhouJian ShiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-17 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Jingyi Liu Zhibing Duan Weijie Guo Lei Zeng Yadi Wu Yule Chen Fang Tai Yifan Wang Yiwei Lin Qiang Zhang Yanling He Jiong Deng Rachel L. Stewart Chi Wang Pengnian Charles Lin Saghi Ghaffari B. Mark Evers Suling Liu Ming-Ming Zhou Binhua P. Zhou Jian Shi Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
description |
The molecular mechanism underlying the resistance of AKT inhibitors in breast cancer is still elusive. Here, the authors demonstrate that BRD4/FOXO3a axis upregulates CDK6 promoter activity to promote resistance to AKT inhibition in breast cancer cells and that blocking the action of CDK6 re-sensitizes resistant cancer cells to growth inhibition. |
format |
article |
author |
Jingyi Liu Zhibing Duan Weijie Guo Lei Zeng Yadi Wu Yule Chen Fang Tai Yifan Wang Yiwei Lin Qiang Zhang Yanling He Jiong Deng Rachel L. Stewart Chi Wang Pengnian Charles Lin Saghi Ghaffari B. Mark Evers Suling Liu Ming-Ming Zhou Binhua P. Zhou Jian Shi |
author_facet |
Jingyi Liu Zhibing Duan Weijie Guo Lei Zeng Yadi Wu Yule Chen Fang Tai Yifan Wang Yiwei Lin Qiang Zhang Yanling He Jiong Deng Rachel L. Stewart Chi Wang Pengnian Charles Lin Saghi Ghaffari B. Mark Evers Suling Liu Ming-Ming Zhou Binhua P. Zhou Jian Shi |
author_sort |
Jingyi Liu |
title |
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
title_short |
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
title_full |
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
title_fullStr |
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
title_full_unstemmed |
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer |
title_sort |
targeting the brd4/foxo3a/cdk6 axis sensitizes akt inhibition in luminal breast cancer |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/47361ecca973405cbbf1642486398298 |
work_keys_str_mv |
AT jingyiliu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT zhibingduan targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT weijieguo targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT leizeng targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT yadiwu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT yulechen targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT fangtai targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT yifanwang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT yiweilin targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT qiangzhang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT yanlinghe targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT jiongdeng targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT rachellstewart targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT chiwang targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT pengniancharleslin targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT saghighaffari targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT bmarkevers targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT sulingliu targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT mingmingzhou targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT binhuapzhou targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer AT jianshi targetingthebrd4foxo3acdk6axissensitizesaktinhibitioninluminalbreastcancer |
_version_ |
1718387020989988864 |